Building Your Care Team: Preparing for Your First Visit
At a Glance
Managing hepatocellular carcinoma requires a multidisciplinary care team, including a hepatologist, oncologists, and specialized surgeons. For your first visit, ensure your case is reviewed by a tumor board and provide raw imaging files (DICOM) and pathology slides for an accurate treatment plan.
Managing Hepatocellular Carcinoma (HCC) is not a one-person job. Because this cancer involves both a tumor and an underlying liver condition, it requires a “multidisciplinary” approach. Research consistently shows that patients who are treated by a specialized team—rather than a single doctor—have better survival rates, higher quality of life, and lower anxiety [1][2][3].
Your Multidisciplinary Roster
A high-quality care team for HCC should include specialists from several different fields. This team often meets behind the scenes in a Multidisciplinary Tumor Board (MDTB) to discuss your case and reach a consensus on the best treatment [4][5].
- Hepatologist: A liver specialist who manages your underlying liver health, such as cirrhosis or hepatitis [6].
- Surgical Oncologist or Transplant Surgeon: Experts who evaluate if the tumor can be safely removed or if a liver transplant is an option [5].
- Interventional Radiologist: A specialist who performs minimally invasive procedures like TACE (chemoembolization) or ablation [5].
- Medical Oncologist: A doctor who specializes in systemic treatments, such as immunotherapy or targeted drugs [5].
- Supportive Care Team: Includes nurse navigators, dietitians, and social workers who help manage symptoms and logistics [7].
- Financial Navigator: A professional who helps manage the heavy financial burden (“financial toxicity”) of cancer treatments. You should proactively ask to speak with one to understand your insurance coverage and assistance programs.
Vetting Your Care Team
Not all hospitals have the same level of expertise in treating liver cancer. You should feel empowered to “interview” your potential team to ensure you are receiving the highest standard of care [8]. Consider asking:
- “Is my case being reviewed by a Multidisciplinary Tumor Board?” The standard of care is a team-based consensus, not a single doctor’s opinion [4].
- “How many HCC cases does this center treat per year?” Centers with higher volumes of HCC patients often have better outcomes and more experience managing complex complications [9].
- “Do you have a dedicated Liver Transplant program?” Even if you don’t need a transplant today, having a transplant surgeon on your team ensures that this curative option is part of your long-term plan [10].
Preparing Your “Consultation Kit”
To get the most out of your first visit, you must provide the new team with the “raw data” of your diagnosis. Written reports are helpful, but the specialists will want to review the source files [11][12].
Mandatory Artifacts to Request
Before your appointment, contact the facilities where your tests were performed and arrange for:
- Imaging Discs (DICOM Files): Ask for the raw image files of your CTs and MRIs on a CD or via a digital transfer portal. The team’s radiologist will want to re-interpret the scans [13].
- Pathology Slide Review: If you have had a biopsy or surgery, do not attempt to pick up the slides yourself. Instead, formally ask your new care team to “request a slide review” from the original hospital. They will securely transport the tissue blocks so their own pathologist can perform specialized testing [11].
- Full Lab History: A printout of your recent blood work, specifically including your AFP (Alpha-fetoprotein) levels, liver enzymes, and kidney function tests [14].
- Medical Summary: A list of previous liver treatments (like past TACE or ablation), your hepatitis status, and any history of alcohol or fatty liver disease.
By arriving with these records and a clear understanding of the team’s roles, you ensure that your first consultation is focused on building an actionable plan.
Common questions in this guide
Why do I need a multidisciplinary tumor board for HCC?
Which specialists should be on my liver cancer care team?
What medical records do I need for my first HCC consultation?
How do I transfer pathology slides to a new cancer center?
Why is a financial navigator important for my care team?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How often does your Multidisciplinary Tumor Board (MDTB) meet to discuss cases like mine?
- 2.Will my case be reviewed by a transplant surgeon, even if we aren't currently planning for a transplant?
- 3.What is the annual volume of HCC patients treated at this center, and what are your typical outcomes for my specific stage?
- 4.Does your center have financial navigators or social workers to help me manage the costs of my treatment?
- 5.Will I have a dedicated point of contact, like a nurse navigator, to help coordinate between the different specialists on my team?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival.
Agarwal PD, Phillips P, Hillman L, et al.
Journal of clinical gastroenterology 2017; (51(9)):845-849 doi:10.1097/MCG.0000000000000825.
PMID: 28877082 - 2
Effect of multidisciplinary team care on patient survival in chronic hepatitis B or C hepatocellular carcinoma.
Tseng YC, Kung PT, Peng CY, et al.
Frontiers in oncology 2023; (13()):1251571 doi:10.3389/fonc.2023.1251571.
PMID: 38179172 - 3
Effect of multi-disciplinary team care program on quality of life, anxiety, and depression in hepatocellular carcinoma patients after surgery: A randomized, controlled study.
Yang L, Yan C, Wang J
Frontiers in surgery 2022; (9()):1045003 doi:10.3389/fsurg.2022.1045003.
PMID: 36684377 - 4
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Benson AB, D'Angelica MI, Abbott DE, et al.
Journal of the National Comprehensive Cancer Network : JNCCN 2021; (19(5)):541-565.
PMID: 34030131 - 5
Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
Taouli B, Ba-Ssalamah A, Chapiro J, et al.
European radiology 2023; (33(12)):9167-9181 doi:10.1007/s00330-023-09919-z.
PMID: 37439935 - 6
New concepts in the treatment of hepatocellular carcinoma.
Sidali S, Trépo E, Sutter O, Nault JC
United European gastroenterology journal 2022; (10(7)):765-774 doi:10.1002/ueg2.12286.
PMID: 35975347 - 7
Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review.
Cheeley MK, Kirkpatrick CF, Brown EE, et al.
Journal of clinical lipidology 2025; (19(4)):737-747 doi:10.1016/j.jacl.2025.05.002.
PMID: 40483195 - 8
Hepatocellular carcinoma: From diagnosis to treatment.
Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, et al.
Surgical oncology 2016; (25(2)):74-85.
PMID: 27312032 - 9
Developing Cancer Quality of Care Indicators to Quantify the Impact of a Global Destabilization of the Care System (COLLAT-COVID).
Piazzon N, Haesebaert J, Michel P, et al.
Cancers 2025; (17(10)) doi:10.3390/cancers17101680.
PMID: 40427177 - 10
The importance of a multidisciplinary approach to hepatocellular carcinoma.
Siddique O, Yoo ER, Perumpail RB, et al.
Journal of multidisciplinary healthcare 2017; (10()):95-100 doi:10.2147/JMDH.S128629.
PMID: 28360525 - 11
Clinically Uncertain Liver Masses: A Guide to Distinguishing Poorly Differentiated Primary Liver Cancer.
Sökeland G, Brönnimann MP, Vassella E, et al.
Biomedicines 2025; (13(5)) doi:10.3390/biomedicines13051063.
PMID: 40426891 - 12
Role of liver biopsy in hepatocellular carcinoma.
Di Tommaso L, Spadaccini M, Donadon M, et al.
World journal of gastroenterology 2019; (25(40)):6041-6052 doi:10.3748/wjg.v25.i40.6041.
PMID: 31686761 - 13
Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics.
Liu N, Wu Y, Tao Y, et al.
Cancers 2023; (15(22)) doi:10.3390/cancers15225373.
PMID: 38001633 - 14
Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinoma.
Liang L, Pang JS, Gao RZ, et al.
Abdominal radiology (New York) 2025; (50(8)):3516-3529 doi:10.1007/s00261-025-04799-x.
PMID: 39907719
This guide on preparing for an HCC consultation is for educational purposes only. Always consult with your hepatologist and oncology team for personalized medical advice and treatment planning.
Get notified when new evidence is published on Adult hepatocellular carcinoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.